In the latest session, Zoetis Inc (NYSE: ZTS) closed at $190.82 down -3.79% from its previous closing price of $198.33. In other words, the price has decreased by -$7.51 from its previous closing price. On the day, 3724316 shares were traded. ZTS stock price reached its highest trading level at $196.23 during the session, while it also had its lowest trading level at $188.49.
Ratios:
For a deeper understanding of Zoetis Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 42.81 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 53.90. For the most recent quarter (mrq), Quick Ratio is recorded 2.00 and its Current Ratio is at 3.36. In the meantime, Its Debt-to-Equity ratio is 1.36 whereas as Long-Term Debt/Eq ratio is at 1.35.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stifel on January 12, 2024, Reiterated its Buy rating but revised its target price to $215 from $195 previously.
On December 07, 2023, Exane BNP Paribas started tracking the stock assigning a Outperform rating and target price of $237.Exane BNP Paribas initiated its Outperform rating on December 07, 2023, with a $237 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 20 when PECK KRISTIN C sold 13,000 shares for $187.20 per share. The transaction valued at 2,433,636 led to the insider holds 79,366 shares of the business.
Lagano Roxanne sold 923 shares of ZTS for $172,878 on Feb 20. The Executive Vice President now owns 16,646 shares after completing the transaction at $187.30 per share. On Feb 13, another insider, Lagano Roxanne, who serves as the Executive Vice President of the company, sold 2,848 shares for $186.86 each. As a result, the insider received 532,177 and left with 17,569 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZTS now has a Market Capitalization of 87.37B and an Enterprise Value of 92.09B. As of this moment, Zoetis’s Price-to-Earnings (P/E) ratio for their current fiscal year is 37.63, and their Forward P/E ratio for the next fiscal year is 29.30. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.74. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.23 while its Price-to-Book (P/B) ratio in mrq is 17.50. Its current Enterprise Value per Revenue stands at 10.78 whereas that against EBITDA is 25.12.
Stock Price History:
Over the past 52 weeks, ZTS has reached a high of $201.92, while it has fallen to a 52-week low of $151.03. The 50-Day Moving Average of the stock is 193.28, while the 200-Day Moving Average is calculated to be 180.60.
Shares Statistics:
For the past three months, ZTS has traded an average of 2.01M shares per day and 2.6M over the past ten days. A total of 458.37M shares are outstanding, with a floating share count of 457.47M. Insiders hold about 0.09% of the company’s shares, while institutions hold 95.47% stake in the company. Shares short for ZTS as of Feb 15, 2024 were 3.41M with a Short Ratio of 1.70, compared to 2.75M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.74% and a Short% of Float of 0.74%.
Dividends & Splits
According to the company, the forward annual dividend rate for ZTS is 1.56, from 1.50 in the trailing year. Against a Trailing Annual Dividend Yield of 0.76%, it implies a Forward Annual Dividend Yield of 0.91%. The stock’s 5-year Average Dividend Yield is 0.62.
Earnings Estimates
There are 10 different market analysts currently analyzing its stock. On average, analysts expect EPS of $1.36 for the current quarter, with a high estimate of $1.45 and a low estimate of $1.3, while EPS last year was $1.31. The consensus estimate for the next quarter is $1.51, with high estimates of $1.58 and low estimates of $1.47.
Analysts are recommending an EPS of between $6.04 and $5.66 for the fiscal current year, implying an average EPS of $5.81. EPS for the following year is $6.51, with 15 analysts recommending between $6.99 and $6.17.
Revenue Estimates
A total of 8 analysts believe the company’s revenue will be $2.17B this quarter.It ranges from a high estimate of $2.28B to a low estimate of $2.11B. As of the current estimate, Zoetis Inc’s year-ago sales were $2.01B, an estimated increase of 8.10% from the year-ago figure. For the next quarter, 8 analysts are estimating revenue of $2.33B, an increase of 7.60% less than the figure of $8.10% in the same quarter last year. There is a high estimate of $2.38B for the next quarter, whereas the lowest estimate is $2.29B.
A total of 16 analysts have provided revenue estimates for ZTS’s current fiscal year. The highest revenue estimate was $9.33B, while the lowest revenue estimate was $9.13B, resulting in an average revenue estimate of $9.19B. In the same quarter a year ago, actual revenue was $8.54B, up 7.60% from the average estimate. Based on 16 analysts’ estimates, the company’s revenue will be $9.85B in the next fiscal year. The high estimate is $10.16B and the low estimate is $9.7B. The average revenue growth estimate for next year is up 7.20% from the average revenue estimate for this year.
